280 related articles for article (PubMed ID: 33583389)
1. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
[TBL] [Abstract][Full Text] [Related]
2. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
Kimura N
Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
[TBL] [Abstract][Full Text] [Related]
3. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254
[TBL] [Abstract][Full Text] [Related]
4. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Stanley M; Macauley SL; Holtzman DM
J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
[TBL] [Abstract][Full Text] [Related]
5. Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results.
Takenoshita N; Shimizu S; Kanetaka H; Sakurai H; Suzuki R; Miwa T; Odawara M; Ishii K; Shimada H; Higuchi M; Suhara T; Hanyu H
J Alzheimers Dis; 2019; 71(1):261-271. PubMed ID: 31356213
[TBL] [Abstract][Full Text] [Related]
6. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
Zemva J; Schubert M
Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
[TBL] [Abstract][Full Text] [Related]
7. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
[TBL] [Abstract][Full Text] [Related]
9. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
12. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's Disease.
Sarkar P; Banu S; Bhattacharya S; Bala A; Sur D
Curr Diabetes Rev; 2023; 19(5):e130522204763. PubMed ID: 35570545
[TBL] [Abstract][Full Text] [Related]
14. The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.
Desai GS; Zheng C; Geetha T; Mathews ST; White BD; Huggins KW; Zizza CA; Broderick TL; Babu JR
J Alzheimers Dis; 2014; 42(2):347-56. PubMed ID: 24858405
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
16. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234
[TBL] [Abstract][Full Text] [Related]
17. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
Caccamo A; Belfiore R; Oddo S
Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
[TBL] [Abstract][Full Text] [Related]
18. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
Rhein V; Eckert A
Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
[TBL] [Abstract][Full Text] [Related]
19. Amylin as a potential link between type 2 diabetes and alzheimer disease.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Riverol M; Marcilla I; de Andrea CE; Sánchez-Arias JA; Del Mar Carmona-Abellan M; Marti G; Erro ME; Martínez-Vila E; Tuñon MT; Luquin MR
Ann Neurol; 2019 Oct; 86(4):539-551. PubMed ID: 31376172
[TBL] [Abstract][Full Text] [Related]
20. (Pre)diabetes, brain aging, and cognition.
S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
